Kringle Pharma Competitors and Similar CompaniesClear all
Kringle Pharma's competitors and similar companies include Pharmacyclics.
 Kringle Pharma Kringle Pharma is a clinical-stage biopharmaceutical company that focuses on the research and development of regenerative medicines. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | |
Founding Date | Founding Date 2001 | Founding Date 1991 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Ibaraki, JP HQ | Locations Sunnyvale, US HQ |
Employees | Employees 13 | Employees 6551% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) ¥72.2m (FY, 2025) | Revenue (est.) $729.7m (FY, 2014) |
Cost of goods | Cost of goods N/A | Cost of goods $40.4m (FY, 2014) |
Gross profit | Gross profit ¥72.2m (FY, 2025) | Gross profit $689.3m (FY, 2014) |
Net income | Net income (¥916.3m) (FY, 2025) | Net income $86.1m (FY, 2014) |
For sources of this data, please see the company profile
View Company Profiles
Pharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company